(Q35966944)

11 August 2017

1 reference

title

Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). (English)

1 reference

inflammatory bowel diseases

11 August 2017

main subject

0 references

author name string

Chandran P

1

1 reference

11 August 2017

Satthaporn S

2

1 reference

11 August 2017

Robins A

3

1 reference

11 August 2017

Eremin O

4

1 reference

11 August 2017

publication date

1 June 2003

1 reference

Journal of the Royal College of Surgeons of Edinburgh

11 August 2017

published in

1 reference

11 August 2017

volume

1

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

125-136

1 reference

Infections in the immunopathogenesis of chronic inflammatory bowel disease

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Microbial factors in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Prevalence of inflammatory bowel disease amongst Mormons in Britain and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

A meta-analysis of the role of smoking in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Transdermal nicotine for active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Neonatal appendectomy impairs mucosal immunity in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Immune response to orally consumed antigens and probiotic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Mechanisms confining indigenous bacteria to the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Molecular genetic features reflecting the preference for isotype switching to IgA expression by Peyer′s patch germinal center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Increase in the Population of Duodenal Immunoglobulin A Plasmocytes in Axenic Mice Associated with Different Living or Dead Bacterial Strains of Intestinal Origin

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

How bacteria talk to each other: regulation of gene expression by quorum sensing.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Quorum Sensing in Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Serum antibodies to Bacteroides species in chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Bacteria and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

1 reference

7 January 2021

Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Perinatal measles infection and subsequent Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Detection of persistent measles virus infection in Crohn's disease: current status of experimental work

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Double blind, placebo controlled trial of metronidazole in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Combination ciprofloxacin and metronidazole for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Probiotics: effects on immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

The intrauterine and postnatal environments

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Role of the bactericidal/permeability-increasing protein in host defence.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Impaired innate immunity at birth: deficiency of bactericidal/permeability-increasing protein (BPI) in the neutrophils of newborns

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Activation of nuclear factor kappa B inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Passage of dietary antigens into the blood of children with coeliac disease. Quantification and size distribution of absorbed antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

A comparative analysis of two models of colitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Modulation of colonic barrier function by the composition of the commensal flora in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Intestinal permeability in Crohn's disease patients and their first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2803%2980091-4

7 January 2021

10.1016/S1479-666X(03)80091-4

Identifiers

DOI

1 reference

11 August 2017

1 reference